Skip to Main Content

Author Details

Donna R Rivera
Oncology Center of Excellence
2012
50
16
PMIDPaper TitleJournal TitlePublished Year
36860658Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data.Cancer Res Commun2023
37496608A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021-February 2022.Open Forum Infect Dis2023
37197442Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma.JHEP Rep2023
36790088The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibody Using Real-World and Trial Data.Clin Pharmacol Ther2023
34655228Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot.Clin Pharmacol Ther2022
35440047Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data.Blood Cancer J2022
35641221Blurring the Lines of Design: Prospective Observational Cohorts and Pragmatic Clinical Trials Characterizing Treatment Effects in Routine Cancer Care.Oncologist2022
35359803Development of a bayesian toxo-equivalence model between docetaxel and paclitaxel.iScience2022
35561304Increasing Inclusiveness of Patient-Centric Clinical Evidence Generation in Oncology: Real-World Data and Clinical Trials.Am Soc Clin Oncol Educ Book2022
35483002Cancer Registry Data Linkage of Electronic Health Record Data From ASCO's CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned.JCO Clin Cancer Inform2022
35187516Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium.Lancet Healthy Longev2022
34964981An overview of real-world data sources for oncology and considerations for research.CA Cancer J Clin2022
35333502Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress.Cancer J2022
34893494Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer.Cancer Discov2022
34664259The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies.Clin Pharmacol Ther2022
33411619Chemotherapy Knowledge Base Management in the Era of Precision Oncology.JCO Clin Cancer Inform2021
33910935The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology.Clin Cancer Res2021
33746047Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.Ann Oncol2021
34673922ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology.Blood Adv2021
34426413Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis.Cancer Epidemiol Biomarkers Prev2021
34272262Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain.Cancer Epidemiol Biomarkers Prev2021
34014037Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems.Cancer Rep (Hoboken)2021
33411620Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research.JCO Clin Cancer Inform2021
32401271Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.JAMA Dermatol2020
31950565Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility.Pharmacoepidemiol Drug Saf2020
31684770Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs.Amyotroph Lateral Scler Frontotemporal Degener2020
33251998Population-based utilization and costs associated with tyrosine kinase inhibitors for first-line treatment of chronic myelogenous leukemia among elderly patients.J Manag Care Spec Pharm2020
32699031Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.Cancer Discov2020
32922297COVID-19 Usurps Host Regulatory Networks.Front Pharmacol2020
32386166Knowledge Graph-Enabled Cancer Data Analytics.IEEE J Biomed Health Inform2020
32412077Utilization of the Cancer Medications Enquiry Database (CanMED)-National Drug Codes (NDC): Assessment of Systemic Breast Cancer Treatment Patterns.J Natl Cancer Inst Monogr2020
32412076Updated Overview of the SEER-Medicare Data: Enhanced Content and Applications.J Natl Cancer Inst Monogr2020
32412073An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program.J Natl Cancer Inst Monogr2020
32412072Development and Utility of the Observational Research in Oncology Toolbox: Cancer Medications Enquiry Database-Healthcare Common Procedure Coding System (HCPCS).J Natl Cancer Inst Monogr2020
30700443Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States.Cancer Epidemiol Biomarkers Prev2019
31590146Long-Term Patterns of Oral Anticancer Agent Adoption, Duration, and Switching in Patients With CML.J Natl Compr Canc Netw2019
31472732The Contribution of Cancer Surveillance Toward Real World Evidence in Oncology.Semin Radiat Oncol2019
31166005Harnessing the Power of Collaboration and Training Within Clinical Data Science to Generate Real-World Evidence in the Era of Precision Oncology.Clin Pharmacol Ther2019
28954296Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.J Natl Cancer Inst2018
35135159Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States.JCO Precis Oncol2018
31112080Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly.Amyotroph Lateral Scler Frontotemporal Degener2018
29494726Questions About Emergency Department Treatment of Patients With Solid Tumors and Hematological Malignant Neoplasms-Reply.JAMA Oncol2018
28954297Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.J Natl Cancer Inst2018
28038980Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs.Clin Lung Cancer2017
28859189Trends in Adult Cancer-Related Emergency Department Utilization: An Analysis of Data From the Nationwide Emergency Department Sample.JAMA Oncol2017
26921969The Emergency Care of Patients With Cancer: Setting the Research Agenda.Ann Emerg Med2016
27663208Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety.Ann Epidemiol2016
27837786Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomes.Ann Epidemiol2016
24311725Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development.Ann Pharmacother2014
23316379Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.ISRN Hematol2012
  • 1 - 50 of 50

Recommended Authors

Mayo Clinic
Career Start Year 2018
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 2
Genesis Research LLC
Career Start Year 2015
Number of shared co-authors 1
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 4
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 1
Department of Pharmacy, 5Peter MacCallum Cancer Centre
Career Start Year 2011
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 2010
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
University of Michigan School of Public Health ann arbor
Career Start Year 2009
Number of shared co-authors 0
Rush University Cancer Center, Rush University Medical Center
Career Start Year 2007
Number of shared co-authors 5
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
The Ottawa Hospital Research Institute
Career Start Year 2005
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Feinberg School of Medicine, Northwestern University
Career Start Year 2003
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 1
Marti Nelson Cancer Foundation
Career Start Year 2003
Number of shared co-authors 2
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 1
Clinical Trials Information Project
Career Start Year 1999
Number of shared co-authors 0
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Wake Forest School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Odette Cancer Centre
Career Start Year 1996
Number of shared co-authors 3
University of California los angeles
Career Start Year 1994
Number of shared co-authors 0
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 1
University of South Carolina
Career Start Year 1986
Number of shared co-authors 5

Collaborators

Vanderbilt University Medical Center
Co-authored papers 7
National Cancer Institute
Co-authored papers 7
National Cancer Institute.
Co-authored papers 4
National Institute of General Medical Sciences
Co-authored papers 3
Center for Research and Analytics, American Society of Clinical Oncology
Co-authored papers 3
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 2
Bloomberg School of Public Health, Johns Hopkins
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
University of Utah Health
Co-authored papers 2
College of Medicine, University of Kentucky, Kentucky Kentucky Cancer Registry
Co-authored papers 2
Co-authored papers 2
Department of Health Services, Brown University School of Public Health
Co-authored papers 2
Co-authored papers 2
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
University of Utah
Co-authored papers 2
Columbia University
Co-authored papers 2
Northeastern University
Co-authored papers 2
Keck School of Medicine, University of Southern California
Co-authored papers 1
HealthPartners Institute
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Ontario Brain Institute
Co-authored papers 1
Columbia University Irving Medical Center
Co-authored papers 1
Digital Health China Technologies Co.
Co-authored papers 1
Universidad del Norte
Co-authored papers 1
Columbia University
Co-authored papers 1
Columbia University Irving Medical Center
Co-authored papers 1
University of Gothenburg
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1